Cargando…
Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846300/ https://www.ncbi.nlm.nih.gov/pubmed/35178370 http://dx.doi.org/10.3389/fpubh.2021.782964 |
_version_ | 1784651832441700352 |
---|---|
author | Huang, Yuankai Huang, Qixiang Xu, Ailin Lu, Mengqing Xi, Xiaoyu |
author_facet | Huang, Yuankai Huang, Qixiang Xu, Ailin Lu, Mengqing Xi, Xiaoyu |
author_sort | Huang, Yuankai |
collection | PubMed |
description | INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants' preferences for six attributes were evaluated via a discrete choice experiment (DCE) using the conditional logit model. Patients' willingness to pay (WTP) for each attribute was calculated based on the cost attribute. RESULTS: The sample consisted of 709 patients (male 51.9%; female 48.1%). The results of the model indicated that patients' preference weight (PW) of days on which the blood glucose level is under control per week was the highest (1.41), and the PW of blood glucose monitoring frequency was the lowest (0.642). Patients were generally willing to pay for improvements in their type 2 diabetes mellitus (T2DM) treatment, and they had relatively higher WTP to avoid the blood glucose level within a normal value of 1 day/week (¥176.01) and also to avoid the frequency of hypoglycemic events within the range of 1–2/month (¥144.53). CONCLUSION: The number of days on which the blood glucose level is under control per week is the most important attribute in the treatment choice for patients with T2DM in China, followed by the frequency of hypoglycemic events, medication regimen, weight change, and blood glucose monitoring. |
format | Online Article Text |
id | pubmed-8846300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88463002022-02-16 Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment Huang, Yuankai Huang, Qixiang Xu, Ailin Lu, Mengqing Xi, Xiaoyu Front Public Health Public Health INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants' preferences for six attributes were evaluated via a discrete choice experiment (DCE) using the conditional logit model. Patients' willingness to pay (WTP) for each attribute was calculated based on the cost attribute. RESULTS: The sample consisted of 709 patients (male 51.9%; female 48.1%). The results of the model indicated that patients' preference weight (PW) of days on which the blood glucose level is under control per week was the highest (1.41), and the PW of blood glucose monitoring frequency was the lowest (0.642). Patients were generally willing to pay for improvements in their type 2 diabetes mellitus (T2DM) treatment, and they had relatively higher WTP to avoid the blood glucose level within a normal value of 1 day/week (¥176.01) and also to avoid the frequency of hypoglycemic events within the range of 1–2/month (¥144.53). CONCLUSION: The number of days on which the blood glucose level is under control per week is the most important attribute in the treatment choice for patients with T2DM in China, followed by the frequency of hypoglycemic events, medication regimen, weight change, and blood glucose monitoring. Frontiers Media S.A. 2022-02-01 /pmc/articles/PMC8846300/ /pubmed/35178370 http://dx.doi.org/10.3389/fpubh.2021.782964 Text en Copyright © 2022 Huang, Huang, Xu, Lu and Xi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Huang, Yuankai Huang, Qixiang Xu, Ailin Lu, Mengqing Xi, Xiaoyu Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title | Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title_full | Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title_fullStr | Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title_full_unstemmed | Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title_short | Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment |
title_sort | patient preferences for diabetes treatment among people with type 2 diabetes mellitus in china: a discrete choice experiment |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846300/ https://www.ncbi.nlm.nih.gov/pubmed/35178370 http://dx.doi.org/10.3389/fpubh.2021.782964 |
work_keys_str_mv | AT huangyuankai patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment AT huangqixiang patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment AT xuailin patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment AT lumengqing patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment AT xixiaoyu patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment |